Find policies, billing codes, payers, states, and providers
Loading...
Create a personalized view of the payer policy updates that matter to you and get notified when changes occur.
Start getting alertsCreate a personalized view of the payer policy updates that matter to you and get notified when changes occur.
Start getting alertsFind policies, billing codes, payers, states, and providers
CPT 17000: Destruction of First or Only Premalignant Skin Lesion
CPT-17003-DESTRUCTION-PREMALIGNANT-LESIONS-ADD-ON-2-14-LESIONSCPT 17003: Destruction of Premalignant Lesions, Add-On (2–14 Lesions)
CPT-17004-DESTRUCTION-15-OR-MORE-PREMALIGNANT-LESIONSCPT 17004: Destruction of 15 or More Premalignant Lesions
CPT-17106-LASER-DESTRUCTION-CUTANEOUS-VASCULAR-LESION-LESS-THAN-10CM2CPT 17106: Laser Destruction of Cutaneous Vascular Lesion <10 cm²
CPT-17107-CUTANEOUS-VASCULAR-LESION-DESTRUCTION-10-50-CM2CPT 17107: Cutaneous Vascular Lesion Destruction, 10–50 cm2
CPT-17108-CUTANEOUS-VASCULAR-DESTRUCTION-GREATER-THAN-50CM2CPT 17108: Cutaneous Vascular Destruction >50 cm2
CPT-17110-DESTRUCTION-BENIGN-CUTANEOUS-LESIONS-1-TO-14CPT 17110: Destruction of Benign Cutaneous Lesions, 1-14
CPT-17111-DESTRUCTION-BENIGN-SKIN-LESIONS-15-OR-MORECPT 17111: Destruction of Benign Skin Lesions, 15 or More
CPT-17250-CHEMICAL-CAUTERIZATION-GRANULATION-TISSUECPT 17250: Chemical Cauterization of Granulation Tissue
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.